FEW men dare to speak its name. But as the first drug specifically designed to treat premature ejaculation proves successful in clinical trials, some critics are questioning whether such treatments are necessary at all.
Jon Pryor at the University of Minnesota, Minneapolis, and colleagues tested the effectiveness of a selective serotonin reuptake inhibitor (SSRI) called dapoxetine on nearly 2000 men with moderate or severe premature ejaculation (PE). Before the trial, these men lasted less than 1 minute after penetration before ejaculating.
After 12 weeks of treatment, the time to ejaculation was 1.8 minutes for men given placebo, 2.8 minutes…
